** Shares in Chr Hansen CHRH.CO rise close to 4%, paring
earlier gains of as much as 5.5%, after the Danish ingredients
maker beat Q2 expectations urn:newsml:reuters.com:*:nASM0006OQ
** Q2 EBIT came in at EUR 84 million ($91.53 million)
against EUR 74 million seen in a company-compiled consensus
** JPMorgan says the positive stock reaction is supported by
solid Q2 beat with volume driven top-line growth and strong
Health & Nutrition
** Credit Suisse also points to this division, saying it has
driven the organic sales growth beat
** Chr Hansen has also raised FY guidance for organic growth
to 7-11% from previously seen 5-8%
** The stock is among top performers on STOXX 600 index
.STOXX
($1 = 0.9177 euros)
(Reporting by Jagoda Darlak)
((jagoda.darlak@tr.com))